Patents Assigned to Bodor Laboratories, Inc.
  • Formulation for soft anticholinergic analogs
    Patent number: 11052067
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: July 6, 2021
    Assignee: Bodor Laboratories, Inc.
    Inventors: Nicholas S. Bodor, John J. Koleng, David Angulo
  • FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
    Publication number: 20170020845
    Abstract: Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
    Type: Application
    Filed: March 12, 2015
    Publication date: January 26, 2017
    Applicant: Bodor Laboratories, Inc.
    Inventors: NICHOLAS S. BODOR, JOHN J. KOLENG, DAVID ANGULO
  • Treatment of eyelid dermatitis
    Patent number: 8835410
    Abstract: A method for the treatment of eyelid dermatitis and/or dermatitis of the periorbital area is provided.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 16, 2014
    Assignee: Bodor Laboratories, Inc.
    Inventor: Nicholas S. Bodor
  • Soft anticholinergic esters
    Patent number: 8628759
    Abstract: Soft anticholinergic esters of the formulas: wherein R1 and R2 are both phenyl or one of R1 and R2 is phenyl and the other is cyclopentyl; R is C1-C8 alkyl, straight or branched chain; and X? is an anion with a single negative charge; and wherein each asterisk marks a chiral center; said compound having the R, S or RS stereoisomeric configuration at each chiral center unless specified otherwise, or being a mixture thereof.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: January 14, 2014
    Assignee: Bodor Laboratories, Inc.
    Inventor: Nicholas S. Bodor